← Back to Clinical Trials
Recruiting NCT05701579

Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment

Trial Parameters

Condition Anterior Cruciate Ligament Injuries
Sponsor Artromedical Konrad Malinowski Clinic
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2022-07-01
Completion 2025-12-31
Interventions
ACL "decompression"

Brief Summary

Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.

Eligibility Criteria

Inclusion Criteria: * patients with ACL degeneratio mucosa decided to undergo a surgical treatment * range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI Exclusion Criteria: * non-adherence to the study protocol * active knee inflammation * range of motion impairment due to other extra- and intra-articular reasons

Related Trials